Home › Funds › Vanguard Personalized Indexing Management, LLC › JNJ

Vanguard Personalized Indexing Management, LLC position in JNJ

JOHNSON JOHNSON · Health Care

Vanguard Personalized Indexing Management, LLC reported holding 364,217 shares of JNJ (JOHNSON JOHNSON) in its Q2 2026 13F filing — a position valued at US$92.5M, representing 0.76% of its reported portfolio and ranking #18 among its reported holdings. Vanguard Personalized Indexing Management, LLC has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)364.22K sh
Reported value held$92.50M
Portfolio Weight0.76%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vanguard Personalized Indexing Management, LLC's JNJ position evolved

Vanguard Personalized Indexing Management, LLC first disclosed a stake in JNJ in Q3 2023 at 137,903 shares (US$21.5M). The position peaked in Q2 2026 at 364,217 shares, worth US$92.5M. Across 12 filings, Vanguard Personalized Indexing Management, LLC increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 364,217 shares valued at US$92.5M — an increase of 19,904 shares quarter over quarter.. Notable position changes include a 37% increase in Q1 2024 (shares fell 8% over the following quarter), a 34% increase in Q3 2024 (shares fell 11% over the following quarter), a 41% increase in Q1 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 137.90K $21.48M New
Q4 2023 118.26K $18.54M Reduce
Q1 2024 161.46K $25.54M Add
Q2 2024 149.66K $16.47M Reduce
Q3 2024 201.05K $32.58M Add
Q4 2024 167.08K $24.16M Reduce
Q1 2025 236.15K $39.16M Add
Q2 2025 267.70K $41.00M Add
Q3 2025 307.24K $57.09M Add
Q4 2025 325.12K $67.28M Add
Q1 2026 344.31K $84.16M Add
Q2 2026 364.22K $92.50M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Vanguard Personalized Indexing Management, LLC held JNJ?

Vanguard Personalized Indexing Management, LLC has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Vanguard Personalized Indexing Management, LLC's current position in JNJ?

As of Q2 2026, Vanguard Personalized Indexing Management, LLC holds 364.22K shares of JNJ (JOHNSON JOHNSON), valued at $92.50M, representing 0.76% of its reported portfolio and ranking #18.

Has Vanguard Personalized Indexing Management, LLC been buying or selling JNJ?

In the latest 13F filing (Q2 2026), Vanguard Personalized Indexing Management, LLC increased its position in JNJ. The position peaked in Q2 2026 at 364.22K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.